Lin, J., Rocha, S., Kwant, K., Dayao, M., Ng, T., Aaron, W., Callihan, E., Gamez-Guerrero, M., Hemmati, G., Wright, K., Barath, M., Xiao, Y., Degree, M., Yu, T., Chew, P., Evans, T., O'Rear, J., Gatto, S., Cremin, M., Yu, S., Patnaik, P., Hundal, A., Austin, R., Lemon, B., & Wesche, H. (n.d.). 632 HPN601 is a protease-activated EpCAM-targeting T cell engager with an improved safety profile for the treatment of solid tumors. Journal for immunotherapy of cancer, 8, A379. http://access.bl.uk/ark:/81055/vdc_100144730263.0x000005